Ashkan Shoamanesh
Director, Hemmorhagic Stroke Research Program · University of California (San Diego) Medical Center
Credentials: ·
History
PresentHemmorhagic Stroke Research Program · University of California (San Diego) Medical Center




- 2008–2012
Doctor of Medicine
Research
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source
New England Journal of Medicine · 2018 · 740 citations
Review · Canadian Journal of Cardiology · 2020 · 443 citations
Canadian Journal of Cardiology · 2018 · 441 citations
- LC
28 papers

19 papers

17 papers

17 papers

17 papers

17 papers

16 papers
- AP
14 papers
Grants
- 2021–2027
StAtins Use in intRacereberal Hemorrhage patieNts MRI (SATURN MRI) Ancillary Study
National Institute of Neurological Disorders and Stroke · U01
PI · $2.1M · Beth Israel Deaconess Medical Center
- 2021–2025
StAtins Use in intRacereberal Hemorrhage patieNts MRI (SATURN MRI) Ancillary Study
National Institute of Neurological Disorders and Stroke · UF1
PI · $2.7M · Beth Israel Deaconess Medical Center
Clinical trials
- 2026–2029
Glucagon-like Peptide-1 Receptor Agonists for Endovascular Stroke Thrombectomy
Principal investigator · Not yet recruiting · Phase 2
Population Health Research Institute
- 2026–2030
Principal investigator · Recruiting
Javelin Medical
- 2022–2024
Colchicine for the Prevention of Vascular Events After an Acute Intracerebral Hemorrhage
Principal investigator · Completed · Phase 2
Population Health Research Institute
- 2019–2026
EdoxabaN foR IntraCranial Hemorrhage Survivors With Atrial Fibrillation (ENRICH-AF)
Principal investigator · Completed · Phase 4
Population Health Research Institute


